Eventually, chronic neuroinflammation can increase the production of proinflammatory IL-6, IL-1β, TNF-α, and other inflammatory mediators; exacerbate neuronal damage; and disrupt insulin signaling pathways, leading to brain insulin resistance—a condition linked to sporadic AD and its progression [28,29,30]. This evidence concerns the gene IL1B and Alzheimer disease.